Clinical trials
Gastroesophageal Reflux trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 6 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 4 |
| 2022 | 1 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Unknown status | 7 |
| Terminated | 6 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 8 |
| Universitaire Ziekenhuizen KU Leuven | 7 |
| Vrije Universiteit Brussel | 5 |
| Takeda | 4 |
| United Pharmaceuticals | 3 |
| Universitair Ziekenhuis Brussel | 3 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 3 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2 |
| Erasme University Hospital | 2 |
| Addex Pharma S.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastroesophageal Reflux | 54 |
| Heartburn | 3 |
| Barrett Esophagus | 2 |
| Esophagitis | 2 |
| Constriction, Pathologic | 1 |
| Critical Illness | 1 |
| Disease | 1 |
| Dyspepsia | 1 |
| Hernia, Hiatal | 1 |
| Mitral Valve Insufficiency | 1 |
Trials
Showing 26 to 50 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.